Intrinsic Value of S&P & Nasdaq Contact Us

Veradigm Inc. MDRX OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
57/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$16.17
+260.1%

Veradigm Inc. (MDRX) — Analyst outlook / Analyst consensus target is. Based on 43 analyst ratings, the consensus is bullish — 1 Strong Buy, 15 Buy, 24 Hold, 2 Sell, 1 Strong Sell.

The consensus price target is $16.17 (low: $10.00, high: $20.00), representing an upside of 260.1% from the current price $4.49.

MDRX Stock — 12-Month Price Forecast

$16.17
▲ +260.13% Upside
Average Price Target
Based on 43 Wall Street analysts offering 12-month price targets for Veradigm Inc., the average price target is $16.17, with a high forecast of $20.00, and a low forecast of $10.00.
The average price target represents a +260.13% change from the last price of $4.49.
Highest Price Target
$20.00
Average Price Target
$16.17
Lowest Price Target
$10.00

MDRX Analyst Ratings

Hold
43
Ratings
16 Buy
24 Hold
3 Sell
Based on 43 analysts giving stock ratings to Veradigm Inc. in the past 3 months
Rating breakdown
Strong Buy
1 2%
Buy
15 35%
Hold
24 56%
Sell
2 5%
Strong Sell
1 2%
37%
Buy
16 analysts
56%
Hold
24 analysts
7%
Sell
3 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message